<HTML>
<HEAD>
<META NAME="Generator" CONTENT="Microsoft Word 97">
<TITLE>FORM 8-K</TITLE>
</HEAD>
<BODY LINK="#0000ff">

<B><FONT FACE="CG Times,Times New Roman"><P ALIGN="CENTER">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C.  20549</P>
</B><P ALIGN="CENTER"></P>
<B><P ALIGN="CENTER">FORM 8-K</P>
</B><P ALIGN="CENTER"></P>
<B><P ALIGN="CENTER">CURRENT REPORT<BR>
Pursuant to Section 13 or 15(d) of the<BR>
Securities Exchange Act of 1934</P>
</B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Date of Report (Date of earliest event reported): May 4, 2005</P>

<P>&nbsp;</P>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mediware Information Systems, Inc.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
</U></FONT><FONT FACE="CG Times,Times New Roman" SIZE=2>(Exact name of registrant as specified in its charter)</P>
</FONT><FONT FACE="CG Times,Times New Roman"><P><BR>
</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=638>
<TR><TD VALIGN="TOP" COLSPAN=4>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1-10768&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11-2209324&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(State or other jurisdiction<BR>
of incorporation)</FONT></TD>
<TD WIDTH="29%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(Commission File Number)</FONT></TD>
<TD WIDTH="38%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=2><P ALIGN="CENTER">(IRS Employer<BR>
Identification No.)</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<P ALIGN="CENTER">&nbsp;</P>
<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11711 West 79th Street, Lenexa, KS&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;66214&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR><TD WIDTH="63%" VALIGN="TOP" COLSPAN=3>
<FONT SIZE=2><P ALIGN="CENTER">(Address of principal executive offices)</FONT></TD>
<TD WIDTH="37%" VALIGN="TOP">
<FONT SIZE=2><P ALIGN="CENTER">(Zip Code)</FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>&nbsp;</TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=4>
<FONT FACE="CG Times,Times New Roman"><P ALIGN="CENTER">Registrant's telephone number, including area code<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(913) 307-1000&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P>
</U></FONT><FONT SIZE=2></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<U><P ALIGN="CENTER">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<BR>
</U>(Former name or former address, if changed since last report)</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P><DIR>
<DIR>

<FONT SIZE=1><P>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P>[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P>[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P>[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P>[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

</FONT><FONT FACE="CG Times,Times New Roman"><P>&nbsp;</P>
</FONT><P>Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Results of Operations and Financial Condition</P>
<P ALIGN="JUSTIFY"></P><DIR>
<DIR>

<P ALIGN="JUSTIFY">&nbsp;&nbsp; On May 4, 2005, Mediware Information Systems, Inc. (the "Company") issued a<BR>
&nbsp;&nbsp; press release announcing its financial results for the quarter ended March 31,<BR>
&nbsp;&nbsp; 2005.  The press release is attached hereto as Exhibit 99.1.  This information<BR>
&nbsp;&nbsp; shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange<BR>
&nbsp;&nbsp; Act of 1934, as amended, and is not incorporated by reference into any filing of<BR>
&nbsp;&nbsp; the Company, whether made before or after the date of this report, regardless of<BR>
&nbsp;&nbsp; any general incorporation language in the filing.</P>
</DIR>
</DIR>

<P>Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial Statements and Exhibits.</P>

<P>(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exhibits.</P>

<P>Exhibit 99.1&nbsp;&nbsp;&nbsp;&nbsp; Press Release of Mediware Information Systems, Inc., dated May 4, 2005,<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; announcing its financial results for the quarter ended March 31, 2005.</P>

<FONT FACE="CG Times,Times New Roman"><P>&nbsp;</P>
<P>&nbsp;</P></DIR>
</DIR>

<B><P ALIGN="CENTER">SIGNATURES</P>
</B><P><BR>
</P>
<P>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P>&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=615>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="55%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>MEDIWARE INFORMATION SYSTEMS, INC</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="55%" VALIGN="TOP">&nbsp;</TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>Date:&#9;May 4, 2005</FONT></TD>
<TD WIDTH="55%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>By:&nbsp;&nbsp;<U>/s/ George J. Barry<BR>
</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;George J. Barry<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Executive Officer and President</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="CG Times,Times New Roman">
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER"><BR>
<B><U>EXHIBIT INDEX</P>
</B></U><P ALIGN="CENTER"><BR>
</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=638>
<TR><TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="CG Times,Times New Roman"><P>Exhibit No.</U><BR>
</FONT></TD>
<TD WIDTH="77%" VALIGN="TOP">
<U><FONT FACE="CG Times,Times New Roman"><P>Description<BR>
</U></FONT></TD>
</TR>
<TR><TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>99.1</FONT></TD>
<TD WIDTH="77%" VALIGN="TOP">
<FONT FACE="CG Times,Times New Roman"><P>Press Release of Mediware Information Systems, Inc., dated May 4, 2005, announcing its financial results for the quarter ended March 31, 2005.</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="CG Times,Times New Roman">
<P>&nbsp;</P>
<P ALIGN="RIGHT">&nbsp;</P>
</FONT><B><P ALIGN="RIGHT">EXHIBIT 99.1</P>
</B>
<I><FONT SIZE=1><P>&nbsp;</P></I></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=513>
<TR><TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>Contact</B></U></FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>George Barry<BR>
913/307-1000<BR>
www.mediware.com</B></U></FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<B><U><FONT SIZE=2><P>Thomas Redington<BR>
203/222-7399<BR>
212/926-1733<BR>
www.redingtoninc.com</B></U></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P><DIR>
<DIR>
<DIR>

<U><P ALIGN="CENTER">Mediware Reports Third Quarter Fiscal 2005 Results</P>
</U><P ALIGN="CENTER"></P>
<P ALIGN="JUSTIFY">LENEXA, KS May 4 -- </B>Mediware Information Systems, Inc. (Nasdaq: MEDW) reported for the quarter ended March 31, 2005, revenue of $9.9 million, up 6 percent from the year-ago period.  Net income for the third quarter of fiscal 2005 was $830,000, or 10 cents per fully diluted share, compared to $561,000, or 7 cents per fully diluted share for the third quarter of fiscal 2004.</P>
<P ALIGN="JUSTIFY">George Barry, Mediware's CEO, said, &quot;The record revenue for the quarter reflects an increasing response to our blood bank product introduction.  Significant advances were achieved on our Medication Management system including obtaining referenceability of our MediMAR product.  Market indications are that acceptance of our products will remain strong.  As previously stated, results for the quarter and near term will continue to be affected by product transition costs and costs associated with Sarbanes-Oxley compliance.&quot;</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P></DIR>
</DIR>
</DIR>

<P ALIGN="CENTER"><CENTER><TABLE BORDER CELLSPACING=1 CELLPADDING=7 WIDTH=566>
<TR><TD VALIGN="TOP" COLSPAN=5>
<B><FONT SIZE=3><P ALIGN="CENTER">Third Quarter and Annual Fiscal<BR>
2005 and 2004 Operating Statement Highlights<BR>
(in thousands) (unaudited):</B></FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=5>&nbsp;</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=3><P ALIGN="CENTER">Three Months<BR>
Ended<BR>
March 31</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=3><P ALIGN="CENTER">Nine Months<BR>
Ended<BR>
March 31</FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="CENTER">2005</U></FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="CENTER">2004</U></FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="CENTER">2005</U></FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="CENTER">2004</U></FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="13%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="12%" VALIGN="MIDDLE">&nbsp;</TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<FONT SIZE=3><P>&nbsp;&nbsp;System Sales</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 3,688 </FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 3,333 </FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;8,905</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;9,173</FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<FONT SIZE=3><P>&nbsp;&nbsp;Services</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 6,193 </FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 5,987 </FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$18,682</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$18,267</FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<FONT SIZE=3><P>Total Revenue</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 9,881</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 9,320</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$27,587</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$27,440</FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<FONT SIZE=3><P>   Operating Expenses</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 8,622</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 8,480</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$23,787</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$23,217</FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<FONT SIZE=3><P>Operating Income </FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ 1,259 </FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;&nbsp;840 </FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;3,800</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;4,223</FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<FONT SIZE=3><P>Net Earnings </FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;&nbsp;830</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;&nbsp;561</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;2,422</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;2,732</FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<FONT SIZE=3><P>Earnings Per Basic Share</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;0.11</FONT></TD>
<TD WIDTH="13%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;0.07</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;&nbsp;0.31</FONT></TD>
<TD WIDTH="12%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;&nbsp;0.37</FONT></TD>
</TR>
<TR><TD WIDTH="51%" VALIGN="TOP">
<FONT SIZE=3><P>Earnings Per Common Share- Diluted (as reported)</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;0.10</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;0.07</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;&nbsp;0.30</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;&nbsp;0.33</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT SIZE=3><P ALIGN="JUSTIFY"></P>
</FONT><P ALIGN="JUSTIFY">&nbsp;</P>
<FONT SIZE=3><P ALIGN="JUSTIFY">&nbsp;</P></FONT>
<P ALIGN="CENTER"><CENTER><TABLE BORDER CELLSPACING=1 CELLPADDING=7 WIDTH=377>
<TR><TD VALIGN="TOP" COLSPAN=3>
<B><FONT SIZE=3><P ALIGN="CENTER">Fiscal 2005 and 2004 Condensed Balance Sheet Highlights<BR>
(in thousands) (unaudited):</B></FONT></TD>
</TR>
<TR><TD VALIGN="TOP" COLSPAN=3>&nbsp;</TD>
</TR>
<TR><TD WIDTH="55%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="45%" VALIGN="TOP" COLSPAN=2>
<FONT SIZE=3><P ALIGN="CENTER">As of the Period Ended<BR>
March 31</FONT></TD>
</TR>
<TR><TD WIDTH="55%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="23%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="CENTER">2005</U></FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<U><FONT SIZE=3><P ALIGN="CENTER">2004</U></FONT></TD>
</TR>
<TR><TD WIDTH="55%" VALIGN="TOP">&nbsp;</TD>
<TD WIDTH="23%" VALIGN="MIDDLE">&nbsp;</TD>
<TD WIDTH="22%" VALIGN="MIDDLE">&nbsp;</TD>
</TR>
<TR><TD WIDTH="55%" VALIGN="MIDDLE">
<FONT SIZE=3><P>Cash and Cash Equivalents</FONT></TD>
<TD WIDTH="23%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$13,013</FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;9,171</FONT></TD>
</TR>
<TR><TD WIDTH="55%" VALIGN="MIDDLE">
<FONT SIZE=3><P>Working Capital</FONT></TD>
<TD WIDTH="23%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$12,064 </FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;8,162</FONT></TD>
</TR>
<TR><TD WIDTH="55%" VALIGN="MIDDLE">
<FONT SIZE=3><P> Long-term Debt</FONT></TD>
<TD WIDTH="23%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36</FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$ &nbsp;1,470</FONT></TD>
</TR>
<TR><TD WIDTH="55%" VALIGN="MIDDLE">
<FONT SIZE=3><P>Stockholders' Equity</FONT></TD>
<TD WIDTH="23%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$33,682</FONT></TD>
<TD WIDTH="22%" VALIGN="MIDDLE">
<FONT SIZE=3><P ALIGN="RIGHT">$28,302</FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT SIZE=3><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P><DIR>

</FONT><B><FONT FACE="Times New Roman Bold" SIZE=3><P>About Mediware</P>
</B></FONT><FONT SIZE=3><P ALIGN="JUSTIFY">Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems.  Its products include HCLL&trade; <I>Transfusion</I>, LifeTrak&reg;, IIE&trade; (Instrument Interface Engine), Hemocare&reg;, LifeLine&trade; (Blood Bank), WORx&reg;, MediCOE&trade;, MediMAR&trade;, Pharmakon&reg;, and Digimedics&trade; (Medication Management), Surgiware&trade; and Perioperative Solutions&trade; (Operating Room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom.  Mediware has over 1,100 systems installed in the US, Canada, the UK, and elsewhere.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="CENTER">#&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;#&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;#</P>
<P ALIGN="CENTER"></P>
</FONT><I><FONT FACE="CG Times,Times New Roman" SIZE=2><P ALIGN="JUSTIFY">&nbsp;&nbsp;&nbsp;Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts</I> <I>and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements. </P>
</I></FONT><FONT SIZE=1><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
</FONT><P ALIGN="JUSTIFY">5/3/05</P>
<B><U><P ALIGN="CENTER"></P></DIR>
</B></U></BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "form8kmay2005.htm", "secsgml_size_bytes": 18830}]
{"company-data": {"conformed-name": "MEDIWARE INFORMATION SYSTEMS INC", "cik": "0000874733", "assigned-sic": "7373", "irs-number": "112209324", "state-of-incorporation": "NY", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-10768", "film-number": "05797120"}, "business-address": {"street1": "11711 WEST 79TH STREET", "city": "LENEXA", "state": "KS", "zip": "66214", "phone": "9133071000"}, "mail-address": {"street1": "11711 WEST 79TH STREET", "city": "LENEXA", "state": "KS", "zip": "66214"}}
FORM 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 4, 2005
Mediware Information Systems, Inc.
(Exact name of registrant as specified in its charter)
New York                                 1-10768                                 11-2209324
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
11711 West 79th Street, Lenexa, KS                                           66214
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code
(913) 307-1000
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02        Results of Operations and Financial Condition
On May 4, 2005, Mediware Information Systems, Inc. (the "Company") issued a
press release announcing its financial results for the quarter ended March 31,
2005.  The press release is attached hereto as Exhibit 99.1.  This information
shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, and is not incorporated by reference into any filing of
the Company, whether made before or after the date of this report, regardless of
any general incorporation language in the filing.
Item 9.01        Financial Statements and Exhibits.
(c)                   Exhibits.
Exhibit 99.1     Press Release of Mediware Information Systems, Inc., dated May 4, 2005,
announcing its financial results for the quarter ended March 31, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDIWARE INFORMATION SYSTEMS, INC
Date:	May 4, 2005
By:
/s/ George J. Barry
George J. Barry
Chief Executive Officer and President
EXHIBIT INDEX
Exhibit No.
Description
99.1
Press Release of Mediware Information Systems, Inc., dated May 4, 2005, announcing its financial results for the quarter ended March 31, 2005.
EXHIBIT 99.1
Contact
George Barry
913/307-1000
www.mediware.com
Thomas Redington
203/222-7399
212/926-1733
www.redingtoninc.com
Mediware Reports Third Quarter Fiscal 2005 Results
LENEXA, KS May 4 --
Mediware Information Systems, Inc. (Nasdaq: MEDW) reported for the quarter ended March 31, 2005, revenue of $9.9 million, up 6 percent from the year-ago period.  Net income for the third quarter of fiscal 2005 was $830,000, or 10 cents per fully diluted share, compared to $561,000, or 7 cents per fully diluted share for the third quarter of fiscal 2004.
George Barry, Mediware's CEO, said, "The record revenue for the quarter reflects an increasing response to our blood bank product introduction.  Significant advances were achieved on our Medication Management system including obtaining referenceability of our MediMAR product.  Market indications are that acceptance of our products will remain strong.  As previously stated, results for the quarter and near term will continue to be affected by product transition costs and costs associated with Sarbanes-Oxley compliance."
Third Quarter and Annual Fiscal
2005 and 2004 Operating Statement Highlights
(in thousands) (unaudited):
Three Months
Ended
March 31
Nine Months
Ended
March 31
2005
2004
2005
2004
System Sales
$ 3,688
$ 3,333
$  8,905
$  9,173
Services
$ 6,193
$ 5,987
$18,682
$18,267
Total Revenue
$ 9,881
$ 9,320
$27,587
$27,440
Operating Expenses
$ 8,622
$ 8,480
$23,787
$23,217
Operating Income
$ 1,259
$    840
$  3,800
$  4,223
Net Earnings
$    830
$    561
$  2,422
$  2,732
Earnings Per Basic Share
$   0.11
$   0.07
$    0.31
$    0.37
Earnings Per Common Share- Diluted (as reported)
$   0.10
$   0.07
$    0.30
$    0.33
Fiscal 2005 and 2004 Condensed Balance Sheet Highlights
(in thousands) (unaudited):
As of the Period Ended
March 31
2005
2004
Cash and Cash Equivalents
$13,013
$  9,171
Working Capital
$12,064
$  8,162
Long-term Debt
$       36
$  1,470
Stockholders' Equity
$33,682
$28,302
About Mediware
Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems.  Its products include HCLL™
Transfusion
, LifeTrak®, IIE™ (Instrument Interface Engine), Hemocare®, LifeLine™ (Blood Bank), WORx®, MediCOE™, MediMAR™, Pharmakon®, and Digimedics™ (Medication Management), Surgiware™ and Perioperative Solutions™ (Operating Room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom.  Mediware has over 1,100 systems installed in the US, Canada, the UK, and elsewhere.
#     #     #
Certain statements in this press release may constitute "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the ``Act'') and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts
and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.
5/3/05